Both PTCA and CABG have their own inherent advantages and disadvantages, which must be weighed in the treatment decision for each patient.
How the Court rules on physician-assisted suicide will spur further legal debate for decades.
The optimal thrombolytic therapy will be a cocktail of several thrombolytic, antithrombotic, and antiplatelet agents, each of which attacks different pathways of clot formation.